Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Barratt

Showing results (1-10 of 272) with videos related to

Pageof 28
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 5, 2025
Disease Modification in Immunoglobulin A NephropathyJonathan Barratt
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 24, 2025
The treatment paradigm in IgAN globally - introductionJonathan Barratt
Nephrology (Carlton, Vic.)|September 27, 2024
Mucosal targeting in IgA nephropathy targeting the gut associated lymphoid tissueJonathan Barratt
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 24, 2025
How should we approach the treatment of IgAN in 2025?Jonathan Barratt
Kidney360|April 4, 2022
Corticosteroids Should Be Used to Treat Slowly Progressive IgA Nephropathy: CONJonathan Barratt
Pediatric Nephrology (Berlin, Germany)|February 1, 2025
Is there sufficient similarity of glomerular diseases across the life course?Louise Oni, Jonathan Barratt
Seminars in Immunopathology|October 27, 2021
IgA nephropathy: a perspective for 2021Jürgen Floege, Jonathan Barratt
Journal of the American Society of Nephrology : JASN|June 3, 2005
IgA nephropathyJonathan Barratt, John Feehally
Frontiers in Immunology|September 27, 2021
Complement Factor D as a Strategic Target for Regulating the Alternative Complement PathwayJonathan Barratt, Ilene Weitz
Kidney Diseases (Basel, Switzerland)|August 19, 2016
The Genetics of IgA Nephropathy: An Overview from Western CountriesJohn Feehally, Jonathan Barratt
Pageof 28

Showing results (1-10 of 272) with videos related to

Sort By:
Pageof 28
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 5, 2025
Disease Modification in Immunoglobulin A NephropathyJonathan Barratt
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 24, 2025
The treatment paradigm in IgAN globally - introductionJonathan Barratt
Nephrology (Carlton, Vic.)|September 27, 2024
Mucosal targeting in IgA nephropathy targeting the gut associated lymphoid tissueJonathan Barratt
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 24, 2025
How should we approach the treatment of IgAN in 2025?Jonathan Barratt
Kidney360|April 4, 2022
Corticosteroids Should Be Used to Treat Slowly Progressive IgA Nephropathy: CONJonathan Barratt
Pediatric Nephrology (Berlin, Germany)|February 1, 2025
Is there sufficient similarity of glomerular diseases across the life course?Louise Oni, Jonathan Barratt
Seminars in Immunopathology|October 27, 2021
IgA nephropathy: a perspective for 2021Jürgen Floege, Jonathan Barratt
Journal of the American Society of Nephrology : JASN|June 3, 2005
IgA nephropathyJonathan Barratt, John Feehally
Frontiers in Immunology|September 27, 2021
Complement Factor D as a Strategic Target for Regulating the Alternative Complement PathwayJonathan Barratt, Ilene Weitz
Kidney Diseases (Basel, Switzerland)|August 19, 2016
The Genetics of IgA Nephropathy: An Overview from Western CountriesJohn Feehally, Jonathan Barratt
Pageof 28